Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 6
1973 8
1974 24
1975 33
1976 17
1977 29
1978 17
1979 16
1980 15
1981 12
1982 10
1983 16
1984 20
1985 20
1986 32
1987 37
1988 30
1989 29
1990 21
1991 21
1992 25
1993 24
1994 24
1995 19
1996 15
1997 16
1998 15
1999 12
2000 6
2001 9
2002 7
2003 12
2004 6
2005 9
2006 12
2007 16
2008 7
2009 9
2010 10
2011 10
2012 5
2013 3
2014 2
2015 2
2016 2
2017 3
2018 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

692 results
Results by year
Filters applied: . Clear all
Page 1
Micro- and nanoparticulates.
Moshfeghi AA, Peyman GA. Moshfeghi AA, et al. Among authors: peyman ga. Adv Drug Deliv Rev. 2005 Dec 13;57(14):2047-52. doi: 10.1016/j.addr.2005.09.006. Epub 2005 Nov 17. Adv Drug Deliv Rev. 2005. PMID: 16298454 Review.
Visual system manifestations of Alzheimer's disease.
Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA. Kusne Y, et al. Among authors: peyman ga. Acta Ophthalmol. 2017 Dec;95(8):e668-e676. doi: 10.1111/aos.13319. Epub 2016 Nov 19. Acta Ophthalmol. 2017. PMID: 27864881 Free article. Review.
Intravitreal Injections: A Historic Background.
Peyman GA. Peyman GA. J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):91-92. doi: 10.4103/jovr.jovr_54_18. J Ophthalmic Vis Res. 2018. PMID: 29719634 Free PMC article. No abstract available.
Intravitreal drug therapy.
Peyman GA, Schulman JA. Peyman GA, et al. Jpn J Ophthalmol. 1989;33(4):392-404. Jpn J Ophthalmol. 1989. PMID: 2696799 Review.
Perfluorocarbon liquids in ophthalmology.
Peyman GA, Schulman JA, Sullivan B. Peyman GA, et al. Surv Ophthalmol. 1995 Mar-Apr;39(5):375-95. doi: 10.1016/s0039-6257(05)80093-1. Surv Ophthalmol. 1995. PMID: 7604361 Review.
Intravitreal triamcinolone acetonide.
Peyman GA, Moshfeghi DM. Peyman GA, et al. Retina. 2004 Jun;24(3):488-90. doi: 10.1097/00006982-200406000-00032. Retina. 2004. PMID: 15187684 No abstract available.
Triamcinolone acetonide in ocular therapeutics.
Jermak CM, Dellacroce JT, Heffez J, Peyman GA. Jermak CM, et al. Among authors: peyman ga. Surv Ophthalmol. 2007 Sep-Oct;52(5):503-22. doi: 10.1016/j.survophthal.2007.06.004. Surv Ophthalmol. 2007. PMID: 17719372 Review.
Applications of liposomes in ophthalmology.
Ebrahim S, Peyman GA, Lee PJ. Ebrahim S, et al. Among authors: peyman ga. Surv Ophthalmol. 2005 Mar-Apr;50(2):167-82. doi: 10.1016/j.survophthal.2004.12.006. Surv Ophthalmol. 2005. PMID: 15749307 Review.
Management of cataract in uveitis patients.
Conway MD, Stern E, Enfield DB, Peyman GA. Conway MD, et al. Among authors: peyman ga. Curr Opin Ophthalmol. 2018 Jan;29(1):69-74. doi: 10.1097/ICU.0000000000000438. Curr Opin Ophthalmol. 2018. PMID: 29095715
Bevacizumab vs. triamcinolone.
Soheilian M, Rabbanikhah Z, Ramezani A, Kiavash V, Yaseri M, Peyman GA. Soheilian M, et al. Among authors: peyman ga. Ophthalmology. 2010 Apr;117(4):855-855.e2. doi: 10.1016/j.ophtha.2009.10.012. Ophthalmology. 2010. PMID: 20346835 Clinical Trial. No abstract available.
692 results